PRUCALOPRIDE SUCCINATE (prucalopride) by Hikma is serotonin 4 receptor agonists [moa]. First approved in 2025.
Drug data last refreshed 21h ago
Serotonin 4 Receptor Agonists
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
A Study of Prucalopride in Breastfeeding Women With Constipation
A Study to Assess Maternal and Fetal Outcomes After Taking Prucalopride During Pregnancy
A Study of Prucalopride For Functional Constipation in Children and Teenagers
Post-Marketing Study of Prucalopride Safety In Pregnancy
Efficacy and Safety of Prucalopride in Combination With Polyethylene Glycol or Lactulose in Women With Chronic Constipation
Worked on PRUCALOPRIDE SUCCINATE at Hikma? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.